药时代BD项目 | 中国大型制药企业希望收购医药制剂生产标的

项目编号:DT-BD-20200412-008

药时代BD项目 | 中国大型制药企业寻找大陆以外医药项目

项目编号:DT-BD-20200412-008

Project Number: DT-BD-20200412-008

项目内容:中国大型制药企业希望收购医药制剂生产标的(降压药支气管药物类等),有糖尿病高血压高血脂大类别药物的药证,有一定规模的制剂生产车间,项目团队稳定,通过一致性评价或者正在做。

Request: Large Chinese pharmaceutical companies are looking to acquire entities for the production of pharmaceuticals (hypertensive drugs, bronchial drugs, etc.). The desired companies are expected to have the drug certificates for large categories of drugs such as diabetes, hypertension, and hyperlipidemia, have a certain scale of production workshops, and the project team is stable. Have passed the BE evaluation or are working on it.

目标领域:降压药、支气管药物类等

Target area: Antihypertensive drugs, bronchial drugs, etc.

目标阶段:通过一致性评价或者正在做

Target stage: Have passed the BE evaluation or are working on it

药物类别:小分子药或者生物药均可

Drug category: small molecule drugs or biological drugs

目标权益:中国大陆

Target right: Mainland China

如果您对该合作机会感兴趣,欢迎与我们联系!我们将与您详细探讨。谢谢!

If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!

联系人 (Contact):Will

电话 (Mobile):13564569657

微信 (Wechat):27674131

邮箱 (E-mail):BD@drugtimes.cn

邮件主题请注明:项目编号:DT-BD-20200412-008

In the e-mail subject, please include “Project Number: DT-BD-20200412-008”

药时代BD项目 | 欧美公司购买中国创新药项目

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

分享本页
返回顶部
药时代BD项目 | 中国大型制药企业希望收购医药制剂生产标的 | 药时代

药时代BD项目 | 中国大型制药企业希望收购医药制剂生产标的

项目编号:DT-BD-20200412-008

药时代BD项目 | 中国大型制药企业寻找大陆以外医药项目

项目编号:DT-BD-20200412-008

Project Number: DT-BD-20200412-008

项目内容:中国大型制药企业希望收购医药制剂生产标的(降压药支气管药物类等),有糖尿病高血压高血脂大类别药物的药证,有一定规模的制剂生产车间,项目团队稳定,通过一致性评价或者正在做。

Request: Large Chinese pharmaceutical companies are looking to acquire entities for the production of pharmaceuticals (hypertensive drugs, bronchial drugs, etc.). The desired companies are expected to have the drug certificates for large categories of drugs such as diabetes, hypertension, and hyperlipidemia, have a certain scale of production workshops, and the project team is stable. Have passed the BE evaluation or are working on it.

目标领域:降压药、支气管药物类等

Target area: Antihypertensive drugs, bronchial drugs, etc.

目标阶段:通过一致性评价或者正在做

Target stage: Have passed the BE evaluation or are working on it

药物类别:小分子药或者生物药均可

Drug category: small molecule drugs or biological drugs

目标权益:中国大陆

Target right: Mainland China

如果您对该合作机会感兴趣,欢迎与我们联系!我们将与您详细探讨。谢谢!

If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!

联系人 (Contact):Will

电话 (Mobile):13564569657

微信 (Wechat):27674131

邮箱 (E-mail):BD@drugtimes.cn

邮件主题请注明:项目编号:DT-BD-20200412-008

In the e-mail subject, please include “Project Number: DT-BD-20200412-008”

药时代BD项目 | 欧美公司购买中国创新药项目

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

分享本页
返回顶部